IN8BIO, INC. (INAB)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch INAB
See up to 3 months of INAB. The 7-day demo opens the 1M and 3M ranges and puts INAB on your watchlist.
Start 7-day demoLatest INAB insider trades
Leslie W. Kreis - 10% OwnerOpen-market purchase709,040 sh- Leslie W. Kreis - 10% OwnerOpen-market purchase709,040 sh
- Aaron G.L. Fletcher - 10% Owner
About IN8BIO, INC. (INAB)
IN8BIO, INC. files with the SEC under CIK 0001740279 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
INAB Form 4 activity by transaction type, last 90 days
No Form 4 activity for INAB in the last 90 days.
INAB insider transactions (Form 4)
4533 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Emily Fairbairn | Gift | Common Stock | 724,637 | $0.00 | - | |
 William Tai-Wei Ho - Officer | Grant or award | Employee Stock Option (right to buy) | 154,500 | $0.00 | - | |
 Luba Greenwood | Grant or award | Stock Option (right to buy) | 22,000 | $0.00 | - | |
| Lawrence Lamb - Officer | Grant or award | Employee Stock Option (right to buy) | 54,000 | $0.00 | - | |
| Emily Fairbairn | Grant or award | Stock Option (right to buy) | 22,000 | $0.00 | - | |
| Patrick McCall - Officer | Grant or award | Employee Stock Option (right to buy) | 56,250 | $0.00 | - | |
 Corinne Epperly | Grant or award | Stock Option (right to buy) | 22,000 | $0.00 | - | |
| Kate Rochlin - Officer | Grant or award | Employee Stock Option (right to buy) | 60,000 | $0.00 | - | |
| Peter C. Brandt | Grant or award | Stock Option (right to buy) | 22,000 | $0.00 | - | |
| Jeremy R. Graff | Grant or award | Stock Option (right to buy) | 22,000 | $0.00 | - | |
| Lawrence Lamb - Officer | Grant or award | Employee Stock Option (right to buy) | 72,000 | $0.00 | - | |
| Patrick McCall - Officer | Grant or award | Employee Stock Option (right to buy) | 75,000 | $0.00 | - | |
| Kate Rochlin - Officer | Grant or award | Employee Stock Option (right to buy) | 80,000 | $0.00 | - | |
| William Tai-Wei Ho - Officer | Grant or award | Employee Stock Option (right to buy) | 206,000 | $0.00 | - | |
| Corinne Epperly | Grant or award | Stock Option (right to buy) | 37,655 | $0.00 | - | |
| Jeremy R. Graff | Grant or award | Stock Option (right to buy) | 47,697 | $0.00 | - | |
| Luba Greenwood | Grant or award | Stock Option (right to buy) | 39,449 | $0.00 | - | |
| Travis Whitfill | Grant or award | Stock Option (right to buy) | 42,676 | $0.00 | - | |
| Patrick McCall - Officer | Grant or award | Employee Stock Option (right to buy) | 290,085 | $0.00 | - | |
| Lawrence Lamb - Officer | Grant or award | Employee Stock Option (right to buy) | 286,899 | $0.00 | - | |
| Kate Rochlin - Officer | Grant or award | Employee Stock Option (right to buy) | 302,839 | $0.00 | - | |
| William Tai-Wei Ho - Officer | Grant or award | Employee Stock Option (right to buy) | 1,188,282 | $0.00 | - | |
| Emily Fairbairn | Grant or award | Stock Option (right to buy) | 31,559 | $0.00 | - | |
| Alan S. Roemer | Grant or award | Stock Option (right to buy) | 93,242 | $0.00 | - | |
| Peter C. Brandt | Grant or award | Stock Option (right to buy) | 49,490 | $0.00 | - | |
| Leslie W. Kreis - 10% Owner | Open-market purchase | Pre-Funded Warrants | 709,040 | - | - | |
| Leslie W. Kreis - 10% Owner | Open-market purchase | Series C Warrant | 709,040 | - | - | |
| Leslie W. Kreis - 10% Owner | Derivative | Series A Warrant | 574,241 | - | - | |
| Leslie W. Kreis - 10% Owner | Grant or award | Series A Warrant | 574,241 | - | - | |
| Aaron G.L. Fletcher - 10% Owner | Open-market purchase | Pre-Funded Warrants | 709,040 | - | - | |
| Aaron G.L. Fletcher - 10% Owner | Open-market purchase | Series C Warrant | 709,040 | - | - | |
| Aaron G.L. Fletcher - 10% Owner | Derivative | Series A Warrant | 574,241 | - | - | |
| Aaron G.L. Fletcher - 10% Owner | Grant or award | Series A Warrant | 574,241 | - | - | |
| Kate Rochlin - Officer | Grant or award | Common Stock | 25,316 | - | - | |
| Kate Rochlin - Officer | Derivative | Series A Warrants (right to buy) | 12,295 | - | - | |
| Kate Rochlin - Officer | Grant or award | Series A Warrants (right to buy) | 12,295 | - | - | |
| Kate Rochlin - Officer | Grant or award | Series C Warrants (right to buy) | 25,316 | - | - | |
| Patrick McCall - Officer | Grant or award | Common Stock | 25,316 | - | - | |
| Patrick McCall - Officer | Derivative | Series A Warrants (right to buy) | 20,492 | - | - | |
| Patrick McCall - Officer | Grant or award | Series A Warrants (right to buy) | 20,492 | - | - | |
| Patrick McCall - Officer | Grant or award | Series C Warrants (right to buy) | 25,316 | - | - | |
| William Tai-Wei Ho - Officer | Grant or award | Common Stock | 126,582 | - | - | |
| William Tai-Wei Ho - Officer | Derivative | Series A Warrants (right to buy) | 81,967 | - | - | |
| William Tai-Wei Ho - Officer | Grant or award | Series A Warrants (right to buy) | 81,967 | - | - | |
| William Tai-Wei Ho - Officer | Grant or award | Series C Warrants (right to buy) | 126,582 | - | - |
Item 2.02
Item 1.01, 1.02, 9.01
Item 2.02, 5.02, 5.07
Item 2.02
INAB insider trading FAQ
What is the latest insider trade for INAB?
IN8BIO, INC. (INAB) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-29. The full record for INAB runs to 33 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying INAB stock?
No insider purchases of INAB were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling INAB stock?
No insider sales of INAB were filed in the last 90 days.
Where can I see INAB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects INAB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Emily Fairbairn view on EDGAR
- - William Tai-Wei Ho view on EDGAR
- - Luba Greenwood view on EDGAR
- - Lawrence Lamb view on EDGAR
- - Emily Fairbairn view on EDGAR
- - Patrick McCall view on EDGAR
- - Corinne Epperly view on EDGAR
- - Kate Rochlin view on EDGAR
- - Peter C. Brandt view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where INAB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow INAB with a 7-day demo
- INAB on your watchlist
- Every INAB Form 4 filing on record
- Up to 3 months of INAB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
